Chiome Bioscience Company
Chiome Bioscience is to commercialize the innovative ADLib'antibody generation technology invented at RIKEN.
Connections
Funding Status:
IPO
Industry:
PharmTech
Technology:
Others
Founded Date:
2005
Headquarters:
Tokyo, Tokyo, Japan
Employee Number:
11-50